E
Emilie H. Zobel
Researcher at Steno Diabetes Center
Publications - 30
Citations - 549
Emilie H. Zobel is an academic researcher from Steno Diabetes Center. The author has contributed to research in topics: Type 2 diabetes & Liraglutide. The author has an hindex of 7, co-authored 23 publications receiving 294 citations.
Papers
More filters
Journal ArticleDOI
Global Changes in Food Supply and the Obesity Epidemic.
Emilie H. Zobel,Tine W. Hansen,Peter Rossing,Peter Rossing,Peter Rossing,Bernt Johan von Scholten +5 more
TL;DR: How a global shift in the food system caused by global economic growth, increase in available food per capita and in food processing is a driver of the obesity epidemic is explored.
Journal ArticleDOI
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY) : a prospective observational study and embedded randomised placebo-controlled trial
Nete Tofte,Morten Lindhardt,Katarina Adamova,Stephan J. L. Bakker,Joachim Beige,Joline W.J. Beulens,Joline W.J. Beulens,Andreas L. Birkenfeld,Gemma Currie,Christian Delles,Ingo Dimos,Lidmila Francová,Marie Frimodt-Møller,Peter Girman,Rüdiger Göke,Tereza Havrdova,Hiddo J.L. Heerspink,Adriaan Kooy,Gozewijn D. Laverman,Harald Mischak,Gerjan Navis,Giel Nijpels,Marina Noutsou,Alberto Ortiz,Aneliya Parvanova,Frederik Persson,John R. Petrie,Piero Ruggenenti,Femke Rutters,Ivan Rychlik,Justyna Siwy,Goce Spasovski,Marijn M. Speeckaert,Matias Trillini,Petra Zürbig,Heiko von der Leyen,Peter Rossing,Peter Rossing,Silke Zimmermann,Silke Zimmermann,Brit Rädisch,Anika Hävemeier,Annette Busmann,Ulrike Wittkop,Barbara Neuhaus,Regina Ax-Smolarski,Veit Zieglschmid,Eva Bollweber,Heidrun Wölk,Viktor Rotbain Curovic,Ninna Hahn Tougaard,Mie K. Eickhoff,Sascha Pilemann-Lyberg,Signe Abitz Winther,Signe Rosenlund,Tine W. Hansen,Bernt Johan von Scholten,Christian Stevns Hansen,Emilie H. Zobel,Jens C. Laursen,Simone Theilade,Lone Jelstrup,Tina R. Juhl,Dorthe Riis,Jessie A. Hermann,Anne G. Lundgaard,Maja L.D. Halkjær,Lene Aabo,Therese Frost Lerche,Maria Lajer,Rikke J. Stefansen,Maria A. Campbell,Annika Durban,Julia Raad,Michael Prigge,Marco Schiemann,Robbie Wilson,Sharon Kean,Elizabeth Douglas,Pamela Surtees,Christina M. Gant,Stanley M H Yeung,Ilse J. M. Hagedoorn,Joanne Flynn,Joe Galloway,Katriona Brooksbank,Carolina Aparicio,Ilian Iliev,Francesco Nones,Francesca Lo Bue,Daniela Melacini,Daniela Cugini,Silvia Prandini,Verusca Lecchi,Svitlana Yakymchuk,Giulia Gherardi,Alessandro Villa,Davide Villa,Flavio Gaspari,Antonio Cannata,Silvia Ferrari,Nadia Stucchi,Šárka Albrechtová,Elina Eldeik,Renata Amanaki,Beatriz Fernandez-Fernandez,Jinny Sanchez-Rodriguez,Clotilde Vázquez,Ana Belen Sanz,Maria Dolores Sanchez-Niño,Adrian M. Ramos,Maria Á. Gonzalo,Ulrike Schmidt,Gjulsen Selim,Tatjana Gjorgovski,Slavica S. Stratrova,Olivera Stojceva-Taneva,Petra Schutten-Westerneng,Brenda Wierbos,Frank Huvers,Anneke K. De Bruin,Bruno Lapauw,Elsie de Man,Kelly Rokegem,Sabien Inion,Kristin Kreutzmann,Isabelle Dewettinck,Caroline Boukens-de Graaf,Ferrina Clerc-de Jong,Jannet Entius,Marian Nannings,Suzy van Steenderen,Friedrich W. Petry,Ceyda Kilic +133 more
TL;DR: This study recruited people with type 2 diabetes, normal urinary albumin excretion, and preserved renal function from 15 specialist centres in ten European countries and tested whether a urinary proteomic risk classifier (CKD273) score was associated with development of microalbuminuria and whether progression to micro Albuminuria could be prevented with the mineralocorticoid receptor antagonist spironolactone.
Journal ArticleDOI
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
Emilie H. Zobel,Bernt Johan von Scholten,Henrik Reinhard,Frederik Persson,Tom Teerlink,Tine W. Hansen,Hans-Henrik Parving,Peter Karl Jacobsen,Peter Rossing,Peter Rossing +9 more
TL;DR: In persons with type 2 diabetes and microalbuminuria higher SDMA was associated with incident cardiovascular disease, all-cause mortality and deterioration in renal function and c statistics and relative integrated discrimination improvement (rIDI) significantly improved risk prediction for all- Cause mortality, and SDMA for deterioration in kidneys function beyond traditional risk factors.
Journal ArticleDOI
Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: A systematic review and meta-analysis.
Natja Launbo,Emilie H. Zobel,Bernt Johan von Scholten,Kristine Færch,Kristine Færch,Peter Godsk Jørgensen,Regitse Højgaard Christensen +6 more
TL;DR: Evidence is provided that exercise, diet, bariatric surgery and pharmaceutical interventions can reduce cardiac adipose tissue volume.
Journal ArticleDOI
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria.
Signe Abitz Winther,Signe Abitz Winther,Peter Henriksen,Josef Korbinian Vogt,Tue H. Hansen,Linda Ahonen,Tommi Suvitaival,Emilie H. Zobel,Marie Frimodt-Møller,Tine W. Hansen,Torben Hansen,Hans-Henrik Parving,Cristina Legido-Quigley,Cristina Legido-Quigley,Peter Rossing,Peter Rossing,Oluf Pedersen +16 more
TL;DR: It is demonstrated that individuals with type 1 diabetes of long duration are characterised by aberrant profiles of gut microbiota and plasma metabolite profiles depending on the level of albuminuria.